Angioedema News and Research

RSS
Angioedema is the rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa and submucosal tissues. It is very similar to urticaria, but urticaria, commonly known as hives, occurs in the upper dermis.
ARNI therapy trial misses target in heart failure, may have selective benefit only

ARNI therapy trial misses target in heart failure, may have selective benefit only

FDA grants approval for generic versions of Lyrica

FDA grants approval for generic versions of Lyrica

Study provides new understanding of mysterious 'hereditary swelling'

Study provides new understanding of mysterious 'hereditary swelling'

New antibody can reduce swelling attacks in patients with hereditary angioedema

New antibody can reduce swelling attacks in patients with hereditary angioedema

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Pediatric antibiotic prescriptions lead to nearly 70,000 ER visits in the U.S. each year

Pediatric antibiotic prescriptions lead to nearly 70,000 ER visits in the U.S. each year

New drug offers hope to prevent attacks of hereditary angioedema

New drug offers hope to prevent attacks of hereditary angioedema

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Joslin scientists suggest new approach to improve stroke therapy

Joslin scientists suggest new approach to improve stroke therapy

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

TARGET My Hives app for people impacted by chronic urticaria now available in Android, iOS systems

TARGET My Hives app for people impacted by chronic urticaria now available in Android, iOS systems

New RNA aptamer can prevent pathogenic protein misfolding

New RNA aptamer can prevent pathogenic protein misfolding

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI